AUTOIMMUNE TECHNOLOGIES, LLC

Biotech · Private

Double chimeric peptide vaccine against disseminated candidiasis

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · autoimmune.com

Sector: Biotech
Total capital: $15M

Federal grants: $225K; 1 award · 2018; Rank in peer group#314 of 392
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: $14.8M; 1 award · Health and Human S; Rank in Biotech#49 of 4373
Granted patents: 5; 6 pending · first 2015; Rank in peer group#25 of 392

Capital timeline

Latest events

Aug 2018Federal grantHealth and Human S · Phase I · Double Chimeric Peptide Vaccine Feasible for Human Use that Protects against Disseminated Candidiasis caused by medically important Candida species$225K
Dec 2013Federal contractHealth and Human S · Igf::ot::igf - Development Of Therapeutic Medical Countermeasures For Biodefense And Emerging Infectious Disease$14.8M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 392 peers

Line = median

Biotech · Molecule

Federal grantsBelow median
Granted patents#25 · top 6%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 5 granted of 11

Jan 21, 2020GrantedImmunogenic Peptide Composition And MethodUSPTOUS 10,537,634
Jul 25, 2019PendingAssay For Anti-polyvinyl Alcohol AntibodiesUSPTOApplication 16373763
Jun 25, 2019GrantedAssay For Anti-polyvinyl Alcohol AntibodiesUSPTOUS 10,330,686

Show all 11 patent records

Immunogenic Peptide Composition And MethodJan 21, 2020 · US 10,537,634Granted
Assay For Anti-polyvinyl Alcohol AntibodiesJul 25, 2019 · Application 16373763Pending
Assay For Anti-polyvinyl Alcohol AntibodiesJun 25, 2019 · US 10,330,686Granted
Immunogenic Peptide Conjugate And Method For Inducing An Anti-influenza Therapeutic Antibody Response TherewithNov 27, 2018 · US 10,137,194Granted
Influenza Inhibiting Compositions And MethodsMay 31, 2016 · US 9,353,157Granted
Compositions And Methods For Coronavirus InhibitionJun 16, 2015 · US 9,056,900Granted
Influenza Inhibiting Compositions And MethodsApplication PCTUS2008007918Pending
Antibodies To Candida And Uses ThereofApplication 62879894Pending
Immunogenic Peptide Conjugate And Method For Inducing An Anti-influenza Therapeutic Antibody Response TherewithApplication PCTUS2014025968Pending
Immunoprotective Primary Mesenchymal Stem Cells And MethodsApplication PCTUS2014025941Pending
Antibodies To Candida And Uses ThereofApplication 62879912Pending

TALPHERA, INC.Similar federal contract value in Biotech · $17M in contracts
BIOPROTECTION SYSTEMS CORPORATIONSimilar federal contract value in Biotech · $15.9M in contracts
REPLIGEN CORPSimilar federal contract value in Biotech · $14.9M in contracts
BLUEWILLOW BIOLOGICS INCSimilar federal contract value in Biotech · $14.7M in contracts
VitriVaxSimilar federal contract value in Biotech · $14.5M in contracts
HDT BIO CORPSimilar federal contract value in Biotech · $14.5M in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.